Evidence map›Paper›PMID 32071186›Full record

ArticleBMJ open2020

Acute rule-out of non-ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial.

Goaris W A Aarts, Cyril Camaro, Robert-Jan van Geuns, Etienne Cramer, Roland R J van Kimmenade, P Damman, Pierre M van Grunsven, Eddy Adang, Paul Giesen, Martijn Rutten and 3 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Performance of the HEART Score in pre-hospital settings for suspected non-ST-elevation acute coronary syndrome: The POPular HEART Study.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
  6. Agreement between ambulance paramedics and physicians on the (pre)hospital identification of low-risk chest pain patients.European journal of emergency medicine : official journal of the European Society for Emergency Medicine · 2026
    Article
  7. Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndrome.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  8. Point-of-care tests in the emergency medical services: a scoping review.Scandinavian journal of trauma, resuscitation and emergency medicine · 2025
    Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Improved prehospital triage for acute cardiac care: results from HART-c, a multicentre prospective study.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2023
    Article
  15. Review
  16. Pre-hospital rule-out of acute coronary syndrome by modified HEART score assessment including point-of-care troponin.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2022
    Article
  17. Article
  18. Performance of a simplified HEART score and HEART-GP score for evaluating chest pain in urgent primary care.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2021
    Article
  19. Article
  20. Pre-hospital point-of-care troponin measurement: a clinical example of its additional value.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Goaris W A AartsCardiology, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0003-4912-295X
Cyril CamaroCardiology, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0001-6170-8318
Robert-Jan van GeunsCardiology, Radboudumc, Nijmegen, The Netherlands.
Etienne CramerCardiology, Radboudumc, Nijmegen, The Netherlands.
Roland R J van KimmenadeCardiology, Radboudumc, Nijmegen, The Netherlands.
P DammanCardiology, Radboudumc, Nijmegen, The Netherlands.
Pierre M van GrunsvenAmbulancezorg, Veiligheidsregio Gelderland-Zuid, Nijmegen, The Netherlands.
Eddy AdangHealth Evidence, Radboudumc, Nijmegen, The Netherlands.
Paul GiesenScientific Institute for Quality of Healthcare, Radboudumc, Nijmegen, The Netherlands.
Martijn RuttenScientific Institute for Quality of Healthcare, Radboudumc, Nijmegen, The Netherlands.
Olaf OuwendijkHuisartsenpost Nijmegen, Nijmegen, The Netherlands.
Marc E R GomesCardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Niels van RoyenCardiology, Radboudumc, Nijmegen, The Netherlands niels.vanroyen@radboudumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBecause of the lack of prehospital protocols to rule out a non-ST-segment elevation acute coronary syndrome (NSTE-ACS), patients with chest pain are often transferred to the emergency department (ED) for thorough evaluation. However, in low-risk patients, an ACS is rarely found, resulting in unnecessary healthcare consumption. Using the HEART (History, ECG, Age, Risk factors and Troponin) score, low-risk patients are easily identified. When a point-of-care (POC) troponin measurement is included in the HEART score, an ACS can adequately be ruled out in low-risk patients in the prehospital setting. However, it remains unclear whether a prehospital rule-out strategy using the HEART score and a POC troponin measurement in patients with suspected NSTE-ACS is cost-effective. METHODS AND ANALYSIS: The ARTICA trial is a randomised trial in which the primary objective is to investigate the cost-effectiveness after 30 days of an early rule-out strategy for low-risk patients suspected of a NSTE-ACS, using a modified HEART score including a POC troponin T measurement. Patients are included by ambulance paramedics and 1:1 randomised for (1) presentation at the ED (control group) or (2) POC troponin T measurement (intervention group) and transfer of the care to the general practitioner in case of a low troponin T value. In total, 866 patients will be included. Follow-up will be performed after 30 days, 6 months and 12 months. ETHICS AND DISSEMINATION: This trial has been accepted by the Medical Research Ethics Committee region Arnhem-Nijmegen. The results of this trial will be disseminated in one main paper and in additional papers with subgroup analyses. TRIAL REGISTRATION NUMBER: Netherlands Trial Register (NL7148).

Indexed as

Acute Coronary SyndromePoint-of-Care SystemsTroponinBiomarkersChest PainElectrocardiographyHospitalsHumansNetherlandsProspective StudiesRandomized Controlled Trials as TopicTroponin TBiomarkersTroponinTroponin Tacute coronary syndromeambulancecost-effectivenessmodified HEART scorepoint-of-care troponinpre-hospital

Identifiers

PMID32071186
PMCPMC7044902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.